tiprankstipranks
BridgeBio Pharma’s Growth Potential and Strategic Positioning: A Buy Recommendation by Tyler Van Buren
PremiumRatingsBridgeBio Pharma’s Growth Potential and Strategic Positioning: A Buy Recommendation by Tyler Van Buren
1d ago
BridgeBio price target raised to $95 from $70 at Cantor Fitzgerald
Premium
The Fly
BridgeBio price target raised to $95 from $70 at Cantor Fitzgerald
2d ago
BridgeBio reports Q4 EPS $1.40 vs. 96c last year
Premium
The Fly
BridgeBio reports Q4 EPS $1.40 vs. 96c last year
2d ago
BridgeBio announces EC marketing authorization for BETONTTRA
PremiumThe FlyBridgeBio announces EC marketing authorization for BETONTTRA
11d ago
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
Premium
The Fly
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
1M ago
BridgeBio Pharma Reports Strong Drug Uptake and Trial Progress
Premium
Company Announcements
BridgeBio Pharma Reports Strong Drug Uptake and Trial Progress
1M ago
BridgeBio receives positive CHMP opinion for acoramidis for ATTR-CM treatment
PremiumThe FlyBridgeBio receives positive CHMP opinion for acoramidis for ATTR-CM treatment
2M ago
BridgeBio participates in a conference call with Cantor Fitzgerald
Premium
The Fly
BridgeBio participates in a conference call with Cantor Fitzgerald
3M ago
BridgeBio Pharma (BBIO) Stock Surges on FDA Approval of Lead Treatment
Premium
Market News
BridgeBio Pharma (BBIO) Stock Surges on FDA Approval of Lead Treatment
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100